Scilex Holding Company Foreign Currency Transaction Gain (Loss), before Tax
Scilex Holding Company (SCLX) reported Foreign Currency Transaction Gain (Loss), before Tax of -$150.00 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2026-08-14
- Scilex Holding Company foreign currency transaction gain (loss), before tax for the quarter ending 2026-06-30 was -$150.00K.
- Scilex Holding Company foreign currency transaction gain (loss), before tax for the quarter ending 2026-03-31 was -$279.00K, a 7075.00% decline year-over-year.
- Scilex Holding Company foreign currency transaction gain (loss), before tax for the quarter ending 2025-12-31 was $183.00K, a 1425.00% increase year-over-year.
- Scilex Holding Company foreign currency transaction gain (loss), before tax for the quarter ending 2025-09-30 was -$2.00K.
- Scilex Holding Company foreign currency transaction gain (loss), before tax for fiscal 2025 was $86.00K.
- Scilex Holding Company foreign currency transaction gain (loss), before tax for fiscal 2024 was -$45.00K.
- Scilex Holding Company foreign currency transaction gain (loss), before tax for fiscal 2023 was -$118.00K.
- Scilex Holding Company foreign currency transaction gain (loss), before tax for fiscal 2022 was -$66.00K.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month | Foreign Currency Transaction Gain (Loss), before Tax 6 month | Foreign Currency Transaction Gain (Loss), before Tax 9 month | Foreign Currency Transaction Gain (Loss), before Tax 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$150.00K 10-Q · filed 2026-08-14 | -$429.00K 10-Q · filed 2026-08-14 | -$246.00K derived: sum of 3 quarters · filed 2026-08-14 | -$248.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2026-03-31 | -$279.00K 10-Q · filed 2026-05-20 | -$96.00K derived: sum of 2 quarters · filed 2026-05-20 | -$98.00K derived: sum of 3 quarters · filed 2026-05-20 | -$197.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-12-31 | $183.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | $181.00K derived: sum of 2 quarters · filed 2026-04-10 | $82.00K derived: sum of 3 quarters · filed 2026-08-14 | $86.00K 10-K · filed 2026-04-10 |
| 2025-09-30 | -$2.00K 10-Q · filed 2025-11-14 | -$101.00K derived: sum of 2 quarters · filed 2026-08-14 | -$97.00K 10-Q · filed 2025-11-14 | -$85.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-06-30 | -$99.00K 10-Q · filed 2026-08-14 | -$95.00K 10-Q · filed 2026-08-14 | -$83.00K derived: sum of 3 quarters · filed 2026-08-14 | -$129.00K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $4.00K 10-Q · filed 2026-05-20 | $16.00K derived: sum of 2 quarters · filed 2026-05-20 | -$30.00K derived: sum of 3 quarters · filed 2026-05-20 | -$35.00K derived: sum of 4 quarters · filed 2026-05-20 |
| 2024-12-31 | $12.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-04-10 | -$34.00K derived: sum of 2 quarters · filed 2026-04-10 | -$39.00K derived: sum of 3 quarters · filed 2026-04-10 | -$45.00K 10-K · filed 2026-04-10 |
| 2024-09-30 | -$46.00K 10-Q · filed 2025-11-14 | -$51.00K derived: sum of 2 quarters · filed 2025-11-14 | -$57.00K 10-Q · filed 2025-11-14 | -$145.00K derived: sum of 4 quarters · filed 2025-11-14 |
| 2024-06-30 | -$5.00K 10-Q · filed 2025-08-13 | -$11.00K 10-Q · filed 2025-08-13 | -$99.00K derived: sum of 3 quarters · filed 2025-08-13 | -$106.00K derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | -$6.00K 10-Q · filed 2025-05-14 | -$94.00K derived: sum of 2 quarters · filed 2025-05-14 | -$101.00K derived: sum of 3 quarters · filed 2025-05-14 | -$104.00K derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | -$88.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-31 | -$95.00K derived: sum of 2 quarters · filed 2025-03-31 | -$98.00K derived: sum of 3 quarters · filed 2025-03-31 | -$118.00K 10-K · filed 2025-03-31 |
| 2023-09-30 | -$7.00K 10-Q · filed 2025-01-17 | -$10.00K derived: sum of 2 quarters · filed 2025-01-17 | -$30.00K 10-Q · filed 2025-01-17 | -$135.00K derived: sum of 4 quarters · filed 2025-01-17 |
| 2023-06-30 | -$3.00K 10-Q · filed 2024-08-13 | -$23.00K 10-Q · filed 2024-08-13 | -$128.00K derived: sum of 3 quarters · filed 2024-08-13 | -$97.00K derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$20.00K 10-Q · filed 2024-05-13 | -$125.00K derived: sum of 2 quarters · filed 2024-05-13 | -$94.00K derived: sum of 3 quarters · filed 2024-05-13 | -$82.00K derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | -$105.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-12 | -$74.00K derived: sum of 2 quarters · filed 2024-03-12 | -$62.00K derived: sum of 3 quarters · filed 2024-03-12 | -$66.00K 10-K · filed 2024-03-12 |
| 2022-09-30 | $31.00K 10-Q · filed 2023-11-14 | $43.00K derived: sum of 2 quarters · filed 2023-11-14 | $39.00K 10-Q · filed 2023-11-14 | |
| 2022-06-30 | $12.00K 10-Q · filed 2023-08-11 | $8.00K 10-Q · filed 2023-08-11 | ||
| 2022-03-31 | -$4.00K 10-Q · filed 2023-05-12 | |||
| 2021-12-31 | -$54.00K 10-K · filed 2024-03-12 | |||
| 2020-12-31 | $2.00K 10-K · filed 2023-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| aTYR PHARMA INC (ATYR) | United States | $0.033B | -0.98 |
| Quince Therapeutics, Inc. (QNCX) | United States | $0.031B | |
| CEL SCI CORP (CVM) | United States | $0.030B | -0.81 |
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| ImageneBio, Inc. (IMA) | United States | $0.056B | -1.31 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |